Author
Listed:
- Ruilong Liu
(University of Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Wenfeng Li
(First Affiliated Hospital of Wenzhou Medical College)
- Bangbao Tao
(Shanghai Jiaotong University)
- Xiongjun Wang
(Guangzhou University)
- Zhuo Yang
(Chinese Academy of Sciences)
- Yajuan Zhang
(University of Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Chenyao Wang
(Cleveland Clinic)
- Rongzhi Liu
(State Administration for Market Regulation)
- Hong Gao
(University of Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Ji Liang
(University of Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Weiwei Yang
(University of Chinese Academy of Sciences
University of Chinese Academy of Sciences)
Abstract
6-Phosphogluconate dehydrogenase (6PGD) is a key enzyme that converts 6-phosphogluconate into ribulose-5-phosphate with NADP+ as cofactor in the pentose phosphate pathway (PPP). 6PGD is commonly upregulated and plays important roles in many human cancers, while the mechanism underlying such roles of 6PGD remains elusive. Here we show that upon EGFR activation, 6PGD is phosphorylated at tyrosine (Y) 481 by Src family kinase Fyn. This phosphorylation enhances 6PGD activity by increasing its binding affinity to NADP+ and therefore activates the PPP for NADPH and ribose-5-phosphate, which consequently detoxifies intracellular reactive oxygen species (ROS) and accelerates DNA synthesis. Abrogating 6PGD Y481 phosphorylation (pY481) dramatically attenuates EGF-promoted glioma cell proliferation, tumor growth and resistance to ionizing radiation. In addition, 6PGD pY481 is associated with Fyn expression, the malignancy and prognosis of human glioblastoma. These findings establish a critical role of Fyn-dependent 6PGD phosphorylation in EGF-promoted tumor growth and radiation resistance.
Suggested Citation
Ruilong Liu & Wenfeng Li & Bangbao Tao & Xiongjun Wang & Zhuo Yang & Yajuan Zhang & Chenyao Wang & Rongzhi Liu & Hong Gao & Ji Liang & Weiwei Yang, 2019.
"Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance,"
Nature Communications, Nature, vol. 10(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08921-8
DOI: 10.1038/s41467-019-08921-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08921-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.